ERBB2 and breast cancer: We observed higher expression of KNSTRN mRNA and protein in triple-negative breast cancer (TNBC) compared to luminal and HER2 types, indicating a potential role of elevated KNSTRN expression in driving the malignant transformation of breast cancers.